Team
Investment Focus
- Criteria
- Partners
- Campuses
- Synthetic Biology
- FAQs
Portfolio
- Case Studies
Fund Manager
Impact
- Economic Value
- Wider Benefits
News
Blog
Contact
- Find Us

Team
Investment Focus
- Criteria
- Partners
- Campuses
- Synthetic Biology
- FAQs
Portfolio
- Case Studies
Fund Manager
Impact
- Economic Value
- Wider Benefits
News
Blog
Contact
- Find Us

Investing In Great Science To Answer Unmet Commercial Needs

“The Rainbow Seed Fund invests at the earliest stages of development, often before a company is formed leveraging its experience and contacts to create a commercially viable proposition.”

Mark White

CRISPR- Cas9 helps blind rats to see

Researchers looking into retinitis pigmentosa have been able to improve vision in rats

Read Blog

Cutting down on the sunscreen could mean heavier crops

Plants get damaged by the sun just like people

Read Blog

Rainbow Seed Fund's £200m Investment in UK’s “Deep Science”

Read More

Andrew Seedhouse: dstl Director

Andrew Seedhouse

Andrew Seedhouse is Chief Technology Office for Rainbow Partner DSTL and Head of The Centre for Defence Enterprise.

Other Team Members

Dr.
Andrew
Muir
Mark
White
Oliver
Sexton
Ian
Taylor
Dr.
Ann
Simon
Kingsley
Manning
Dr.
Chris
Martin
Sean
Sutcliffe
Dr.
David
Lawrence
Tim
Bestwick
Karen
Lewis

Follow Us

Looking for Investment?

Team
Investment Focus
- Criteria
- Partners
- Campuses
- Synthetic Biology
- FAQs
Portfolio
- Case Studies
Fund Manager
Impact
- Economic Value
- Wider Benefits
News
Blog
Contact
- Find Us

Get Updates

want more? we'll get back to
you as soon as possible.

© Rainbow Seed Fund 2016. All Rights Reserved. Midven Limited is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549.
Registered in England and Wales. Company Number 2500898

Registered Address: Midven Limited, Cavendish House, 39-, Birmingham,

| terms and conditions | privacy policy | site map